{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T07:53:46Z","timestamp":1791186826556,"version":"4.1.0"},"reference-count":39,"publisher":"The Endocrine Society","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,4,1]]},"DOI":"10.1210\/jc.2013-3367","type":"journal-article","created":{"date-parts":[[2014,1,16]],"date-time":"2014-01-16T17:53:23Z","timestamp":1389894803000},"page":"1442-1451","source":"Crossref","is-referenced-by-count":122,"title":["Fasting Serum Taurine-Conjugated Bile Acids Are Elevated in Type 2 Diabetes and Do Not Change With Intensification of Insulin"],"prefix":"10.1210","volume":"99","author":[{"given":"Marlene","family":"Wewalka","sequence":"first","affiliation":[{"name":"Joslin Diabetes Center (M.W., M.-E.P., C.B., A.B.G.), Boston, Massachusetts 02215;"},{"name":"Harvard Medical School (M.W., M.-E.P., A.B.G.), Harvard University, Boston, Massachusetts 02115;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary-Elizabeth","family":"Patti","sequence":"additional","affiliation":[{"name":"Joslin Diabetes Center (M.W., M.-E.P., C.B., A.B.G.), Boston, Massachusetts 02215;"},{"name":"Harvard Medical School (M.W., M.-E.P., A.B.G.), Harvard University, Boston, Massachusetts 02115;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinne","family":"Barbato","sequence":"additional","affiliation":[{"name":"Harvard Medical School (M.W., M.-E.P., A.B.G.), Harvard University, Boston, Massachusetts 02115;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sander M.","family":"Houten","sequence":"additional","affiliation":[{"name":"Laboratory Genetic Metabolic Diseases (S.M.H.), Departments of Clinical Chemistry and Pediatrics, Academic Medical Center, 1105 AZ Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison B.","family":"Goldfine","sequence":"additional","affiliation":[{"name":"Joslin Diabetes Center (M.W., M.-E.P., C.B., A.B.G.), Boston, Massachusetts 02215;"},{"name":"Harvard Medical School (M.W., M.-E.P., A.B.G.), Harvard University, Boston, Massachusetts 02115;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"key\n\t\t\t\t2019041113383203900_B1","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1152\/physrev.00010.2008","article-title":"Role of bile acids and bile acid receptors in metabolic regulation","volume":"89","author":"Lefebvre","year":"2009","journal-title":"Physiol Rev"},{"key":"key\n\t\t\t\t2019041113383203900_B2","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1073\/pnas.0506982103","article-title":"Activation of the nuclear receptor FXR improves hyperglycemia and hyperlipidemia in diabetic mice","volume":"103","author":"Zhang","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"key\n\t\t\t\t2019041113383203900_B3","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s11892-011-0187-x","article-title":"Bile acid metabolism and the pathogenesis of type 2 diabetes","volume":"11","author":"Prawitt","year":"2011","journal-title":"Curr Diab Rep"},{"key":"key\n\t\t\t\t2019041113383203900_B4","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.jhep.2010.12.004","article-title":"The bile acid membrane receptor TGR5 as an emerging target in metabolism and inflammation","volume":"54","author":"Pols","year":"2011","journal-title":"J Hepatol"},{"key":"key\n\t\t\t\t2019041113383203900_B5","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1126\/science.1128294","article-title":"Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes","volume":"313","author":"\u00d6zcan","year":"2006","journal-title":"Science"},{"key":"key\n\t\t\t\t2019041113383203900_B6","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/msb.2008.50","article-title":"Metabolic profiling of the human response to a glucose challenge reveals distinct axes of insulin sensitivity","volume":"4","author":"Shaham","year":"2008","journal-title":"Mol Sys Biol"},{"key":"key\n\t\t\t\t2019041113383203900_B7","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1002\/hep.23831","article-title":"Improved glycemic control with colesevelam treatment in patients with type 2 diabetes is not directly associated with changes in bile acid metabolism","volume":"52","author":"Brufau","year":"2010","journal-title":"Hepatology"},{"key":"key\n\t\t\t\t2019041113383203900_B8","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1002\/hep.23408","article-title":"Bile salt sequestration induces hepatic de novo lipogenesis through farnesoid X receptor- and liver X receptor \u03b1-controlled metabolic pathways in mice","volume":"51","author":"Herrema","year":"2010","journal-title":"Hepatology"},{"key":"key\n\t\t\t\t2019041113383203900_B9","doi-asserted-by":"crossref","first-page":"79","DOI":"10.2337\/diab.34.1.79","article-title":"Altered bile acid metabolism in nonobese, spontaneously diabetic (NOD) mice","volume":"34","author":"Uchida","year":"1985","journal-title":"Diabetes"},{"key":"key\n\t\t\t\t2019041113383203900_B10","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1007\/BF01072357","article-title":"Bile lipid composition and bile acid pool size in diabetes","volume":"23","author":"de Leon","year":"1978","journal-title":"Am J Dig Dis"},{"key":"key\n\t\t\t\t2019041113383203900_B11","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1056\/NEJM197706162962401","article-title":"Effects of diabetes mellitus on cholesterol metabolism in man","volume":"296","author":"Bennion","year":"1977","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041113383203900_B12","doi-asserted-by":"crossref","first-page":"903","DOI":"10.2337\/diab.31.10.903","article-title":"Metabolism of cholesterol and plasma triglycerides in nonketotic diabetes mellitus","volume":"31","author":"Abrams","year":"1982","journal-title":"Diabetes"},{"key":"key\n\t\t\t\t2019041113383203900_B13","doi-asserted-by":"crossref","first-page":"e25006","DOI":"10.1371\/journal.pone.0025006","article-title":"Bile acid metabolites in serum: intraindividual variation and associations with coronary heart disease, metabolic syndrome and diabetes mellitus","volume":"6","author":"Steiner","year":"2011","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t2019041113383203900_B14","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1743-7075-8-48","article-title":"Fasting plasma chenodeoxycholic acid and cholic acid concentrations are inversely correlated with insulin sensitivity in adults","volume":"8","author":"Cariou","year":"2011","journal-title":"Nutr Metab (Lond)"},{"key":"key\n\t\t\t\t2019041113383203900_B15","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/1743-7075-7-73","article-title":"Plasma bile acids are not associated with energy metabolism in humans","volume":"7","author":"Brufau","year":"2010","journal-title":"Nutr Metab (Lond)"},{"issue":"12","key":"key\n\t\t\t\t2019041113383203900_B16","doi-asserted-by":"crossref","first-page":"4184","DOI":"10.2337\/db13-0639","article-title":"Human insulin resistance is associated with increased plasma levels of 12\u03b1-hydroxylated bile acids","volume":"62","author":"Haeusler","year":"2013","journal-title":"Diabetes"},{"key":"key\n\t\t\t\t2019041113383203900_B17","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1023\/A:1005543802724","article-title":"Rapid analysis of conjugated bile acids in plasma using electrospray tandem mass spectrometry: application for selective screening of peroxisomal disorders","volume":"22","author":"Bootsma","year":"1999","journal-title":"J Inherit Metab Dis"},{"key":"key\n\t\t\t\t2019041113383203900_B18","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and \u03b2-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"key\n\t\t\t\t2019041113383203900_B19","doi-asserted-by":"crossref","first-page":"335","DOI":"10.2337\/dc08-1478","article-title":"Oral disposition index predicts the development of future diabetes above and beyond fasting and 2-h glucose levels","volume":"32","author":"Utzschneider","year":"2009","journal-title":"Diabetes Care"},{"key":"key\n\t\t\t\t2019041113383203900_B20","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1053\/j.gastro.2006.08.020","article-title":"Utility of a new model to diagnose an alcohol basis for steatohepatitis","volume":"131","author":"Dunn","year":"2006","journal-title":"Gastroenterology"},{"key":"key\n\t\t\t\t2019041113383203900_B21","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1194\/jlr.R900010-JLR200","article-title":"Bile acids: regulation of synthesis","volume":"50","author":"Chiang","year":"2009","journal-title":"J Lipid Res"},{"key":"key\n\t\t\t\t2019041113383203900_B22","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1021\/jm7015864","article-title":"Novel potent and selective bile acid derivatives as TGR5 agonists: biological screening, structure-activity relationships, and molecular modeling studies","volume":"51","author":"Sato","year":"2008","journal-title":"J Med Chem"},{"key":"key\n\t\t\t\t2019041113383203900_B23","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1002\/dmrr.229","article-title":"The role of taurine in diabetes and the development of diabetic complications","volume":"17","author":"Hansen","year":"2001","journal-title":"Diabetes Metab Res Rev"},{"key":"key\n\t\t\t\t2019041113383203900_B24","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1161\/CIRCULATIONAHA.111.067827","article-title":"Metabolite profiling identifies pathways associated with metabolic risk in humans","volume":"125","author":"Cheng","year":"2012","journal-title":"Circulation"},{"key":"key\n\t\t\t\t2019041113383203900_B25","doi-asserted-by":"crossref","first-page":"13580","DOI":"10.1073\/pnas.0804437105","article-title":"Functional and comparative metagenomic analysis of bile salt hydrolase activity in the human gut microbiome","volume":"105","author":"Jones","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"key\n\t\t\t\t2019041113383203900_B26","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.2337\/db07-1403","article-title":"Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet\u2014induced obesity and diabetes in mice","volume":"57","author":"Cani","year":"2008","journal-title":"Diabetes"},{"key":"key\n\t\t\t\t2019041113383203900_B27","doi-asserted-by":"crossref","first-page":"4523","DOI":"10.1073\/pnas.1006734107","article-title":"Systemic gut microbial modulation of bile acid metabolism in host tissue compartments","volume":"108","author":"Swann","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"key\n\t\t\t\t2019041113383203900_B28","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.cmet.2013.01.003","article-title":"Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-\u03b2-muricholic acid, a naturally occurring FXR antagonist","volume":"17","author":"Sayin","year":"2013","journal-title":"Cell Metab"},{"key":"key\n\t\t\t\t2019041113383203900_B29","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.cmet.2009.08.001","article-title":"TGR5-mediated bile acid sensing controls glucose homeostasis","volume":"10","author":"Thomas","year":"2009","journal-title":"Cell Metab"},{"key":"key\n\t\t\t\t2019041113383203900_B30","doi-asserted-by":"crossref","first-page":"E718","DOI":"10.1210\/jc.2012-3961","article-title":"Effects of taurocholic acid on glycemic, glucagon-like peptide-1, and insulin responses to small intestinal glucose infusion in healthy humans","volume":"98","author":"Wu","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113383203900_B31","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1038\/oby.2009.102","article-title":"Serum bile acids are higher in humans with prior gastric bypass: potential contribution to improved glucose and lipid metabolism","volume":"17","author":"Patti","year":"2009","journal-title":"Obesity (Silver Spring)"},{"key":"key\n\t\t\t\t2019041113383203900_B32","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.2337\/db12-0754","article-title":"Metabolite profiles during oral glucose challenge","volume":"62","author":"Ho","year":"2013","journal-title":"Diabetes"},{"key":"key\n\t\t\t\t2019041113383203900_B33","doi-asserted-by":"crossref","first-page":"E384","DOI":"10.1152\/ajpendo.90748.2008","article-title":"Changes of the plasma metabolome during an oral glucose tolerance test: is there more than glucose to look at?","volume":"296","author":"Zhao","year":"2009","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113383203900_B34","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1172\/JCI110668","article-title":"Hepatic uptake of bile acids in man. Fasting and postprandial concentrations of individual bile acids in portal venous and systemic blood serum","volume":"70","author":"Angelin","year":"1982","journal-title":"J Clin Invest"},{"key":"key\n\t\t\t\t2019041113383203900_B35","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1101\/gad.184788.111","article-title":"Endocrine fibroblast growth factors 15\/19 and 21: from feast to famine","volume":"26","author":"Potthoff","year":"2012","journal-title":"Genes Dev"},{"key":"key\n\t\t\t\t2019041113383203900_B36","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/978-1-4614-0887-1_11","article-title":"Physiology of FGF15\/19","volume":"728","author":"Jones","year":"2012","journal-title":"Adv Exp Med Biol"},{"key":"key\n\t\t\t\t2019041113383203900_B37","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1126\/science.1198363","article-title":"FGF19 as a postprandial, insulin-independent activator of hepatic protein and glycogen synthesis","volume":"331","author":"Kir","year":"2011","journal-title":"Science"},{"key":"key\n\t\t\t\t2019041113383203900_B38","doi-asserted-by":"crossref","first-page":"627","DOI":"10.33549\/physiolres.932099","article-title":"Serum concentrations of fibroblast growth factor 19 in patients with obesity and type 2 diabetes mellitus: the influence of acute hyperinsulinemia, very-low calorie diet and PPAR-\u03b1 agonist treatment","volume":"60","author":"Mraz","year":"2011","journal-title":"Physiol Res"},{"key":"key\n\t\t\t\t2019041113383203900_B39","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1080\/00365510701854967","article-title":"Fibroblast growth factor-19: development, analytical characterization and clinical evaluation of a new ELISA test","volume":"68","author":"Stejskal","year":"2008","journal-title":"Scand J Clin Lab Invest"}],"container-title":["The Journal of Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/99\/4\/1442\/9049858\/jcem1442.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,14]],"date-time":"2020-08-14T07:46:37Z","timestamp":1597391197000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/99\/4\/1442\/2537565"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,1]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,4,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2013-3367","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,1]]}}}